Funder
Biogen Idec, Novartis Pharmaceuticals, TEVA, Sanofi-Genzyme and Roche
Subject
Neurology (clinical),Neurology,General Medicine
Reference13 articles.
1. Group AoBNMA. Guidance on the prevention of Listeria infection after alemtuzumab treatment of multiple sclerosis. 2017.
2. Community-acquired Listeria monocytogenes meningitis in adults;Brouwer;Clin. Infect. Dis,2006
3. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis;Coles;N. Engl. J. Med,2008
4. Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient;Decard,2017
5. Targeting of the central nervous system by Listeria monocytogenes;Disson;Virulence,2012
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献